FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118129390> ?p ?o ?g. }

• W3118129390 endingPage "93" @default.
• W3118129390 startingPage "79" @default.
• W3118129390 abstract "Purpose of the study. To determine the effectiveness of antiandrogenic therapy — 10-year General and tumor-specific survival (OV, OSV) depending on the type of hormone therapy, the stage of the disease, and the risk of progression. Patients and methods. The study was based on a retrospective analysis of 100 patients with localized, locally advanced, and metastatic prostate cancer over the period 2008–2018. The assessment was conducted in 2019. All patients received antiandrogenic treatment in the form of castration therapy (n=59) and combined (complex) treatment (n=41) in various variants and modes for more than 5 years. Patients had a 100% 5-year survival rate. The control point of the study was General and tumor- specific survival, as well as prognostic factors that determine this survival. Results. By the end of the study, 53 (53%) patients were alive, 8 (8%) died, and 39 (39%) patients were censored. The highest percentage of 10-year overall survival was achieved in localized stages of the disease and was 52% (31 patients) — stage 1, 38% (22 patients) — stage 2. Tumor specific survival rate (1–2 stages) — 62% (33 patients). At stage 3–30% (14 patients) and 51% (21 patients) and at stage 4–18% (1 patient) and 32% (2 patients), respectively. Depending on the risk of progression (Gleason index), high rates of both General and tumor- specific survival were achieved with low Gleason (2–5), and moderate risk of Gleason progression (6–7), and were 85% and 62%, respectively. The most effective method of treatment that determines the 10-year overall survival was combined (hormone radiation) therapy, which allowed to achieve results in 75% of patients. The tumor — specific survival rate was more than 80%. Conclusion. In real clinical practice, the use of antideprivation therapy in various variants and modes allows to obtain a 10-year General and tumor- specific survival rate in 75% and more than 80% of patients. Stratification of patients by risk groups forms a personalized approach to the treatment of each patient. Use of research treatment regimens in the work STAMPEDE, CHAARTED allows to increase the overall survival of patients with metastatic stage of the disease." @default.
• W3118129390 created "2021-01-05" @default.
• W3118129390 creator A5003912566 @default.
• W3118129390 creator A5062860873 @default.
• W3118129390 creator A5074619608 @default.
• W3118129390 creator A5091030233 @default.
• W3118129390 date "2020-12-22" @default.
• W3118129390 modified "2023-09-26" @default.
• W3118129390 title "Effectiveness of hormone therapy in patients with prostate cancer. Regional experience" @default.
• W3118129390 cites W1981525998 @default.
• W3118129390 cites W1986114421 @default.
• W3118129390 cites W2072903300 @default.
• W3118129390 cites W2112304044 @default.
• W3118129390 cites W2123230901 @default.
• W3118129390 cites W2135078918 @default.
• W3118129390 cites W2168391852 @default.
• W3118129390 cites W2214621962 @default.
• W3118129390 cites W2495045426 @default.
• W3118129390 cites W2766518664 @default.
• W3118129390 cites W2787804990 @default.
• W3118129390 cites W2955947125 @default.
• W3118129390 cites W2958120161 @default.
• W3118129390 doi "https://doi.org/10.17709/2409-2231-2020-7-4-7" @default.
• W3118129390 hasPublicationYear "2020" @default.
• W3118129390 type Work @default.
• W3118129390 sameAs 3118129390 @default.
• W3118129390 citedByCount "0" @default.
• W3118129390 crossrefType "journal-article" @default.
• W3118129390 hasAuthorship W3118129390A5003912566 @default.
• W3118129390 hasAuthorship W3118129390A5062860873 @default.
• W3118129390 hasAuthorship W3118129390A5074619608 @default.
• W3118129390 hasAuthorship W3118129390A5091030233 @default.
• W3118129390 hasBestOaLocation W31181293901 @default.
• W3118129390 hasConcept C121608353 @default.
• W3118129390 hasConcept C126322002 @default.
• W3118129390 hasConcept C126894567 @default.
• W3118129390 hasConcept C143998085 @default.
• W3118129390 hasConcept C146357865 @default.
• W3118129390 hasConcept C151730666 @default.
• W3118129390 hasConcept C2776235491 @default.
• W3118129390 hasConcept C2776283816 @default.
• W3118129390 hasConcept C2778311097 @default.
• W3118129390 hasConcept C2780192828 @default.
• W3118129390 hasConcept C2780275930 @default.
• W3118129390 hasConcept C50382708 @default.
• W3118129390 hasConcept C530470458 @default.
• W3118129390 hasConcept C71924100 @default.
• W3118129390 hasConcept C86803240 @default.
• W3118129390 hasConceptScore W3118129390C121608353 @default.
• W3118129390 hasConceptScore W3118129390C126322002 @default.
• W3118129390 hasConceptScore W3118129390C126894567 @default.
• W3118129390 hasConceptScore W3118129390C143998085 @default.
• W3118129390 hasConceptScore W3118129390C146357865 @default.
• W3118129390 hasConceptScore W3118129390C151730666 @default.
• W3118129390 hasConceptScore W3118129390C2776235491 @default.
• W3118129390 hasConceptScore W3118129390C2776283816 @default.
• W3118129390 hasConceptScore W3118129390C2778311097 @default.
• W3118129390 hasConceptScore W3118129390C2780192828 @default.
• W3118129390 hasConceptScore W3118129390C2780275930 @default.
• W3118129390 hasConceptScore W3118129390C50382708 @default.
• W3118129390 hasConceptScore W3118129390C530470458 @default.
• W3118129390 hasConceptScore W3118129390C71924100 @default.
• W3118129390 hasConceptScore W3118129390C86803240 @default.
• W3118129390 hasIssue "4" @default.
• W3118129390 hasLocation W31181293901 @default.
• W3118129390 hasOpenAccess W3118129390 @default.
• W3118129390 hasPrimaryLocation W31181293901 @default.
• W3118129390 hasRelatedWork W11945040 @default.
• W3118129390 hasRelatedWork W13127835 @default.
• W3118129390 hasRelatedWork W13397619 @default.
• W3118129390 hasRelatedWork W14127037 @default.
• W3118129390 hasRelatedWork W18183186 @default.
• W3118129390 hasRelatedWork W18800992 @default.
• W3118129390 hasRelatedWork W20190482 @default.
• W3118129390 hasRelatedWork W3215447 @default.
• W3118129390 hasRelatedWork W542822 @default.
• W3118129390 hasRelatedWork W9248643 @default.
• W3118129390 hasVolume "7" @default.
• W3118129390 isParatext "false" @default.
• W3118129390 isRetracted "false" @default.
• W3118129390 magId "3118129390" @default.
• W3118129390 workType "article" @default.